Last updated on March 2019

Phase 2/3 Randomized Double-Masked Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)


Brief description of study

This study will determine the effect of QPI-1007 on visual function in subjects with recent-onset NAION and assess the safety and tolerability of intravitreal injections of QPI-1007 in this population. This study will also evaluate the structural changes in the retina following administration of QPI-1007.

Detailed Study Description

This is a double masked, randomized, sham-controlled efficacy and safety study that will enroll approximately 800 subjects with recent-onset NAION. Subjects will be randomized into one of 3 groups in a 1:1:1 ratio, and assigned to receive QPI-1007 and/or a sham procedure. Subjects will have a two in three (66%) chance of receiving active treatment (no sham procedure) and a one in three (33%) chance of receiving sham procedure (no active treatment). Total study time involvement is approximately 12 months.

Clinical Study Identifier: NCT02341560

Find a site near you

Start Over

University of Michigan

Ann Arbor, MI United States
  Connect »

Cape Coral Eye Center

Cape Coral, FL United States
  Connect »

Bethesda Neurology, LLC

Bethesda, MD United States
  Connect »

Sarasota Retina Institute

Sarasota, FL United States
  Connect »

Stanford University

Palo Alto, CA United States
  Connect »

Dean McGee Eye Institute

Oklahoma City, OK United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

Foresight Studies

San Antonio, TX United States
  Connect »

University of Minnesota

Minneapolis, MN United States
  Connect »

University of Southern California

Los Angeles, CA United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

The Eye Care Group

Waterbury, CT United States
  Connect »

Boston Medical Center

Boston, MA United States
  Connect »

NeuroEyeOrbit Institute

Los Angeles, CA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.